PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
49.37%
Net income growth above 1.5x TSM's 31.23%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
1.92%
D&A growth well above TSM's 1.85%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
28.95%
Deferred tax of 28.95% while TSM is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
16.27%
Less SBC growth vs. TSM's 141.56%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-1470.69%
Both reduce yoy usage, with TSM at -1166.70%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
58.39%
AR growth well above TSM's 100.00%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-254.58%
Negative yoy inventory while TSM is 100.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-40.75%
Negative yoy AP while TSM is 0.54%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-185.92%
Both reduce yoy usage, with TSM at -624.86%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
100.79%
Some yoy increase while TSM is negative at -30.19%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
15.50%
Operating cash flow growth above 1.5x TSM's 9.21%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
3.81%
Some CapEx rise while TSM is negative at -4.54%. John Neff would see competitor possibly building capacity while we hold back expansions.
-100.00%
Both yoy lines negative, with TSM at -24376.03%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-110.27%
Negative yoy purchasing while TSM stands at 14.31%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
11.20%
We have some liquidation growth while TSM is negative at -23.30%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-104.21%
Both yoy lines negative, with TSM at -41.75%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-610.76%
Both yoy lines negative, with TSM at -14.27%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
87.52%
We repay more while TSM is negative at -9.62%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
-24.13%
We cut yoy buybacks while TSM is 100.01%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.